These findings support the therapeutic potential of NC in AD and underscore the broader relevance of targeting neurotrophin- and IR-mediated signalling cascades in the development of disease-modifying treatments for neurodegenerative disorders [89,90]. The gene discussed is BDNF; the disease is Alzheimer disease.